About
Technology
Issues
FAQ
Links
Official Page
Early phase II study of S-1, a new oral fluoropyrimidine, for advanced non-small-cell lung cancer
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.